US healthcare-equipment maker CR Bard is flying high a day after Becton Dickinson, the New Jersey-based medical technology company, struck a $24bn cash-and-shares takeover deal for the company.

The company’s shares hit an all-time intraday high of $305.66 before pulling back slightly to trade at $304.10 a share at pixel time, a 20 per cent increase from Friday’s close and on track for its highest closing price ever, according to Bloomberg data.

In the deal announced on Sunday, Becton offered $222.93 in cash and 0.5077 of its own shares in return for each Bard share, for a total value of $317 per share based on BD’s closing price on Friday.

Becton did not enjoy the same day-after bounce as its target, as it plans to borrow heavily to finance the deal, its second large acquisition in three years following its $12.2bn purchase of CareFusion in 2015. Becton shares were trading down 3.6 per cent by Monday afternoon, putting them on track for their biggest one-day drop since November.

Copyright The Financial Times Limited 2022. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this article


Comments have not been enabled for this article.